MIV 150

CAS No. 231957-54-3

MIV 150 ( PC-815;MIV150 )

Catalog No. M13656 CAS No. 231957-54-3

A high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1323 Get Quote
50MG 2682 Get Quote
100MG 3600 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MIV 150
  • Note
    Research use only, not for human use.
  • Brief Description
    A high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM.
  • Description
    A high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM; possesses poor oral bioavailability, and demonstrates efficacy when formulated as a topical microbicide (PC-815: Carrageenan gel formulation).HIV Infection Phase 1 Clinical
  • Synonyms
    PC-815;MIV150
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    231957-54-3
  • Formula Weight
    368.40
  • Molecular Formula
    C19H17FN4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N[C@@H]1[C@H](C2=C(F)C=CC(C(CC)=O)=C2O)C1)NC3=NC=C(C#N)C=C3
  • Chemical Name
    N-(5-Cyano-2-pyridinyl)-N'-[(1S,2S)-2-[6-fluoro-2-hydroxy-3-(1-oxopropyl)phenyl]cyclopropyl]urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Geitmann M, et al. J Med Chem. 2006 Apr 20;49(8):2367-74.
2. Fernández-Romero JA, et al. Sex Transm Dis. 2007 Jan;34(1):9-14.
3. Singer R, et al. Sci Transl Med. 2012 Sep 5;4(150):150ra123.
molnova catalog
related products
  • TAT 48-57

    TAT (48-57) is a cell-permeable peptide, derived from HIV-1 transactivator of transcription (Tat) protein residue 48-57.This peptide is amino acid residues 48 to 57 fragment of the basic domain of HIV Tat.

  • GSK-2838232

    GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.

  • Fosamprenavir calciu...

    A phosphate ester prodrug of the HIV-1 protease inhibitor amprenavir with improved solubility.